全球心臟植入市場

到 2030 年全球心臟植入市場規模將達到 578 億美元

全球心臟植入市場規模預計在2024年達到375億美元，預計在2024-2030年的分析期內將以7.5%的複合年成長率成長，到2030年將達到578億美元。植入式心臟整流去顫器是本報告分析的細分市場之一，預計其複合年成長率將達到9.4%，到分析期結束時規模將達到164億美元。心律調節器細分市場在分析期間的複合年成長率預計將達到8.6%。

美國市場預計將達到 102 億美元，中國市場複合年成長率將達到 11.9%

美國心臟植入市場規模預計2024年達到102億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到124億美元，在2024-2030年的分析期間內，複合年成長率為11.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.6%和7.3%。在歐洲，預計德國市場的複合年成長率為4.9%。

全球心臟植入市場—主要趨勢與促進因素摘要

為什麼心臟植入成為心血管疾病管理的核心？

心臟植入擴大被用作治療和管理各種心血管疾病的挽救生命和改善生活的醫療設備。隨著心律不整、冠狀動脈疾病和心臟心臟衰竭等心臟相關疾病的全球負擔持續增加，這些植入在恢復正常心臟功能和提高患者存活率方面發揮著至關重要的作用。心臟植入包括各種各樣的設備，例如心律調節器、植入式心臟整流去顫器(ICD)、心臟再同步治療 (CRT) 設備、輔助人工心臟(VAD) 和心臟瓣膜。每種設備都有其特定的功能，例如調節不規則心率或為衰弱的心臟提供機械支撐。全球人口老化，加上久坐不動的生活方式和不良的飲食習慣，導致心血管疾病急劇增加，刺激了對有效治療方法的需求。心臟植入不僅提供治療益處，還提供透過遠端監控進行診斷的能力，使醫生能夠即時追蹤患者的心臟功能並及時做出臨床決策。微創手術的需求也推動了新一代植入的採用，這些植入物可減少手術創傷並加速康復。對於許多末期心臟疾病患者來說，植入是器官移植的唯一替代方案。隨著已開發經濟體和新興經濟體對早期診斷認知的不斷提高以及醫療技術可近性的改善，心臟植入已成為現代心血管治療策略的重要組成部分。

科技創新如何影響現代心臟植入的設計與功能？

技術進步正在迅速改變心臟植入，使其更小、更聰明、更有效。最顯著的發展之一是設備的小型化，從而可以實現微創植入並提高患者的舒適度。這些較小的植入還具有更長的電池壽命和更高的電源效率，減少了頻繁更換的需要。無線通訊和藍牙遙測的結合引入了即時遠端監控，允許從植入到醫生的監控系統的連續數據傳輸。這種連接不僅提高了診斷的準確性，而且還可以在設備故障或患者病情惡化時進行主動干預。現在，人工智慧演算法和數據分析平台正在整合以分析心律、預測併發症和個人化治療。無導線心律調節器的出現解決了與傳統導線相關的併發症，降低了感染和機械故障的風險。生物相容性材料和先進的塗層技術透過減少發炎反應和改善長期功能，進一步提高了植入的安全性。對於心臟衰竭患者，新一代輔助人工心臟體積較小、噪音較小，使其更適合日常生活，並能減輕患者的心理困擾。此外，生物可吸收支架和組織工程心臟瓣膜的突破，為植入物鋪平了道路，這些植入能夠隨著時間的推移自然地適應身體，尤其適用於那些已經長大到無法再使用傳統裝置的兒童和年幼患者。機器人輔助植入技術的創新也提高了手術精準度，縮短了手術時間。隨著技術的不斷發展，心臟植入的設計也越來越注重適應、學習和預測治療方案，以及每位患者的獨特需求。

哪些地理和人口模式推動了全球對心臟植入的需求？

全球對心臟植入的需求受到區域醫療保健動態、人口變化和疾病流行模式等多種因素的影響。北美，尤其是美國和加拿大，是心臟植入的主要市場，因為該地區心血管疾病發生率高、醫療保健基礎設施先進、報銷政策優惠。歐洲的植入式設備數量正在增加，德國、法國和英國等國家在早期診斷和介入性心臟病學方面投入了大量資金。在亞太地區，快速的都市化、生活方式的改變以及高血壓、糖尿病和肥胖症的增加導致心臟病患者數量激增。中國、印度和日本等國的醫療成本正在上升，同時政府也努力擴大都市區地區的心臟照護設施。隨著治療意識和治療機會的改善，這些國家正在成為心臟植入製造商有希望的市場。在拉丁美洲和中東部分地區，不斷擴張的私人醫療保健行業和醫療旅遊業正在推動需求成長，但高昂的設備成本和有限的報銷額度仍然是一些地區的障礙，因為老年人口更容易患心律不整、心臟衰竭和瓣膜退化。然而，患有先天性心臟疾病和遺傳性疾病的年輕患者也受益於專為長期使用和降低併發症發生率而設計的新型植入技術。心血管篩檢計畫和專科醫療中心的擴張進一步提高了診斷率，這與所有年齡層和地區的植入量增加直接相關。

推動全球心臟植入市場成長的關鍵因素有哪些？

心臟植入市場的成長受到多種強大力量的推動，特別是流行病學趨勢、技術創新、醫療保健基礎設施以及患者期望的變化。首先，由於人口老化和肥胖、吸菸和糖尿病等生活方式相關的風險因素，全球心血管疾病的盛行率不斷上升，對植入等介入解決方案的需求也日益成長。同時，無導線心律調節器、智慧感測器和 MRI 相容設備等植入技術的改進正在擴大心臟裝置的臨床範圍和安全性。微創手術的推動也在影響需求。新的植入物設計可以實現更快的恢復和更短的住院時間，這在基於價值的醫療保健系統中是越來越重要的指標。遠端醫療和遠端監控技術的擴展正在改善植入後的護理和依從性，從而提高這些治療方法的長期成功率。患者和臨床醫生對早期治療方案的認知不斷提高，從而可以更早地進行診斷和植入干預，從而改善患者的治療效果。在新興市場，醫療保健投資的不斷成長、保險涵蓋範圍的改善以及專業心臟中心的建立，使得包括植入的各種醫療程序更容易為患者所接受。此外，致力於降低心血管死亡率的政府和非政府醫療保健計劃正在為廣泛的篩檢和基於設備的治療提供資金支持。最後，醫療設備公司和醫療保健提供者之間的策略夥伴關係正在改善分銷、培訓和上市後支持，加速植入在先前滲透不足的市場中的普及。這些因素共同確保了全球心臟植入市場的持續擴張，並鞏固了其在當前和未來心血管護理中的關鍵作用。

部分

產品（植入式心臟整流去顫器、心臟節律器、冠狀動脈支架、植入式心率監測器、植入式血流動力學監測器、其他產品）、應用（心律不整應用、急性心肌梗塞應用、心肌缺血應用、其他應用）、最終用戶（醫院最終用戶、循環系統中心最終用戶、其他最終用戶）

受訪公司範例

• Abiomed, Inc.
• Abbott Laboratories
• B. Braun Melsungen AG
• Berlin Heart GmbH
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• Cook Medical Incorporated
• CryoLife, Inc.
• Edwards Lifesciences Corporation
• Jarvik Heart, Inc.
• Johnson & Johnson（Ethicon/BIOL）
• Lepu Medical Technology Co., Ltd.
• LivaNova plc
• Medico SpA
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• Zimmer Biomet Holdings, Inc.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Cardiac Implants Market to Reach US$57.8 Billion by 2030

The global market for Cardiac Implants estimated at US$37.5 Billion in the year 2024, is expected to reach US$57.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Implantable Cardioverter-defibrillators, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$16.4 Billion by the end of the analysis period. Growth in the Pacemakers segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.2 Billion While China is Forecast to Grow at 11.9% CAGR

The Cardiac Implants market in the U.S. is estimated at US$10.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.4 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Cardiac Implants Market - Key Trends & Drivers Summarized

Why Are Cardiac Implants Becoming Central to the Management of Cardiovascular Disorders?

Cardiac implants are increasingly being adopted as life-saving and life-enhancing medical devices in the treatment and management of a wide spectrum of cardiovascular diseases. As the global burden of heart-related conditions such as arrhythmias, coronary artery disease, and heart failure continues to rise, these implants are playing a pivotal role in restoring normal cardiac function and improving patient survival rates. Cardiac implants encompass a diverse range of devices including pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, ventricular assist devices (VADs), and heart valves. Each of these serves a specialized function, from regulating irregular heartbeats to providing mechanical support for weakened hearts. The growing prevalence of aging populations across the world, coupled with increasingly sedentary lifestyles and poor dietary habits, has contributed to a surge in cardiovascular ailments, further elevating the need for effective interventions. Cardiac implants offer not only therapeutic benefits but also diagnostic capabilities through remote monitoring features, allowing physicians to track a patient’s heart function in real time and make timely clinical decisions. The demand for minimally invasive procedures is also bolstering the adoption of newer-generation implants that require less surgical trauma and offer faster recovery. For many patients with end-stage heart disease, implants represent the only viable alternative to transplantation. The growing awareness of early diagnosis and the improved accessibility of healthcare technologies in both developed and emerging economies continue to make cardiac implants an integral component of modern cardiovascular care strategies.

How Are Technological Innovations Shaping the Design and Functionality of Modern Cardiac Implants?

Technological advancements are rapidly transforming the landscape of cardiac implants, making them smaller, smarter, and significantly more effective. One of the most notable developments is the miniaturization of devices, allowing for less invasive implantation and improved patient comfort. These smaller implants also come with longer battery lives and enhanced power efficiency, reducing the need for frequent replacements. The incorporation of wireless communication and Bluetooth-enabled telemetry has introduced real-time remote monitoring, enabling continuous data transmission from the implant to the physician’s monitoring system. This connectivity is not only enhancing diagnostic precision but also allowing for proactive intervention in cases of device malfunction or patient deterioration. AI algorithms and data analytics platforms are now being integrated to analyze heart rhythms, anticipate complications, and personalize treatment. The emergence of leadless pacemakers has addressed complications associated with traditional leads, offering reduced risk of infection and mechanical failure. Biocompatible materials and advanced coating technologies have further improved the safety profile of implants by reducing inflammatory responses and improving long-term functionality. For patients with heart failure, new-generation VADs are now smaller and quieter, making them more suitable for daily life and reducing psychological distress. Additionally, breakthroughs in bioresorbable scaffolds and tissue-engineered heart valves are paving the way for implants that can be naturally integrated into the body over time, particularly in pediatric or younger patients who outgrow traditional devices. Innovations in robotic-assisted implantation techniques are also improving procedural accuracy and reducing operation times. As technology continues to evolve, cardiac implants are increasingly being designed not only to treat but also to adapt, learn, and predict patient-specific needs.

What Regional and Demographic Patterns Are Driving Global Demand for Cardiac Implants?

The global demand for cardiac implants is being influenced by a combination of regional healthcare dynamics, demographic shifts, and disease prevalence patterns. In North America, particularly in the United States and Canada, high rates of cardiovascular disease combined with advanced healthcare infrastructure and favorable reimbursement policies have made the region a leading market for cardiac implants. Europe follows closely, with countries such as Germany, France, and the UK investing heavily in early diagnosis and interventional cardiology, thereby maintaining robust adoption of implantable devices. In Asia-Pacific, rapid urbanization, lifestyle changes, and increasing incidence of hypertension, diabetes, and obesity are contributing to a sharp rise in heart disease cases. Countries like China, India, and Japan are witnessing growing healthcare expenditures, along with government initiatives to expand cardiac care facilities in both urban and rural areas. As awareness and access to treatment improve, these countries are emerging as high-potential markets for cardiac implant manufacturers. In Latin America and parts of the Middle East, expanding private healthcare sectors and medical tourism are facilitating increased demand, although high device costs and limited reimbursement remain barriers in certain areas. Demographically, the aging global population is a key demand driver, as older adults are significantly more susceptible to arrhythmias, heart failure, and valve degeneration. However, younger patients with congenital heart defects or genetic conditions are also benefiting from new implant technologies designed for long-term use and lower complication rates. The widening reach of cardiovascular screening programs and specialist care centers is further increasing the diagnosis rates, which directly correlates with higher implant volumes across all age groups and regions.

What Are the Key Drivers Propelling Growth in the Global Cardiac Implants Market?

The growth in the cardiac implants market is driven by several powerful forces centered around epidemiological trends, technological innovation, healthcare infrastructure, and shifting patient expectations. First and foremost, the rising global prevalence of cardiovascular diseases, fueled by aging populations and lifestyle-related risk factors such as obesity, smoking, and diabetes, is creating a consistently high need for interventional solutions like implants. Simultaneously, ongoing improvements in implant technology, including leadless pacemakers, smart sensors, and MRI-compatible devices, are expanding the clinical scope and safety profile of cardiac devices. The push for minimally invasive procedures is also influencing demand, as new implant designs allow for faster recovery and reduced hospital stays, which are increasingly important metrics in value-based healthcare systems. The expansion of telemedicine and remote monitoring technologies is facilitating better post-implant care and compliance, increasing the long-term success rates of these interventions. Increased awareness among both patients and clinicians regarding early treatment options is resulting in earlier diagnosis and implant intervention, improving patient outcomes. In emerging markets, growing healthcare investments, improved access to insurance, and the establishment of cardiac specialty centers are enabling more patients to undergo procedures involving implants. Moreover, government and non-government health initiatives focusing on reducing cardiovascular mortality are supporting widespread screening and funding for device-based treatment. Finally, strategic partnerships between medical device companies and healthcare providers are improving distribution, training, and post-market support, accelerating the adoption of implants in previously underpenetrated markets. Together, these factors are ensuring sustained expansion of the global cardiac implants market, reinforcing its critical role in contemporary and future cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Cardiac Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors, Other Products); Application (Arrhythmias Application, Acute Myocardial Infarction Application, Myocardial Ischemia Application, Other Applications); End-User (Hospitals End-Users, Cardiology Centers End-Users, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abiomed, Inc.
• Abbott Laboratories
• B. Braun Melsungen AG
• Berlin Heart GmbH
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• Cook Medical Incorporated
• CryoLife, Inc.
• Edwards Lifesciences Corporation
• Jarvik Heart, Inc.
• Johnson & Johnson (Ethicon/BIOL)
• Lepu Medical Technology Co., Ltd.
• LivaNova plc
• Medico S.p.A.
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Cardiac Implants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Burden of Cardiovascular Diseases Throws the Spotlight on Cardiac Implants as Life-Saving Interventions
  • Increasing Aging Population Spurs Demand for Long-Term Implantable Solutions for Heart Rhythm and Structural Disorders
  • Here's the Story: How Advancements in Minimally Invasive Procedures Are Expanding Access to Cardiac Implant Therapies
  • Technological Innovations in Pacemakers, Defibrillators, and Heart Valves Strengthen Business Case for Next-Gen Devices
  • Growth in Transcatheter and Leadless Implant Technologies Fuels Market Expansion Across Risk Categories
  • Here's How Remote Monitoring and Smart Implants Are Reshaping Post-Operative Cardiac Care
  • Rising Adoption of Left Ventricular Assist Devices (LVADs) and Artificial Hearts Drives Demand in Advanced Heart Failure Management
  • Global Expansion of Electrophysiology Labs and Structural Heart Programs Supports Implant Procedure Volumes
  • Growing Awareness and Screening Initiatives Drive Early Diagnosis and Prophylactic Implantation
  • Rising Burden of Lifestyle-Related Risk Factors Fuels Preventive Use of Cardiac Rhythm Management Devices
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cardiac Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cardiac Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Implantable Cardioverter-defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Implantable Cardioverter-defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Implantable Cardioverter-defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Implantable Heart Rhythm Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Implantable Heart Rhythm Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Implantable Heart Rhythm Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Implantable Hemodynamic Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Implantable Hemodynamic Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Implantable Hemodynamic Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Arrhythmias Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Acute Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Acute Myocardial Infarction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Acute Myocardial Infarction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Myocardial Ischemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Myocardial Ischemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Myocardial Ischemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Hospitals End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Cardiology Centers End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Cardiology Centers End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Cardiology Centers End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• JAPAN
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• CHINA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• EUROPE
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Cardiac Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• FRANCE
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: France 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• GERMANY
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Germany 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Italy 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: UK 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Spain 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Russia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Cardiac Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Australia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• INDIA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: India 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: South Korea 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Cardiac Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Latin America 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Argentina 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Brazil 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Mexico 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Cardiac Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Cardiac Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Middle East 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Iran 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Israel 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: UAE 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030
• AFRICA
  • Cardiac Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Cardiac Implants by Product - Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Cardiac Implants by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter-defibrillators, Pacemakers, Coronary Stents, Implantable Heart Rhythm Monitors, Implantable Hemodynamic Monitors and Other Products for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Cardiac Implants by Application - Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Cardiac Implants by Application - Percentage Breakdown of Value Sales for Other Applications, Arrhythmias Application, Acute Myocardial Infarction Application and Myocardial Ischemia Application for the Years 2014, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Cardiac Implants by End-user - Hospitals End-Users, Cardiology Centers End-Users and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Africa 16-Year Perspective for Cardiac Implants by End-user - Percentage Breakdown of Value Sales for Hospitals End-Users, Cardiology Centers End-Users and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION